Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
Discovery & DevelopmentSCHOTT Pharma Unveils Next-Generation Polymer Syringe System
4 min read • 2 years ago -
Manufacturing ServicesTanvex BioPharma Completes Acquisition of Bora Biologics
4 min read • 2 years ago -
NewsAdare Pharma Solutions Expands in Pennsylvania, Welcomes Governor Shapiro
4 min read • 2 years ago -
Discovery & DevelopmentTerumo Launches Injection Filter Needle as Part of INFINO™ Development Program
4 min read • 2 years ago -
-
Formulation ServicesRegeneron Acquires Oxular to Expand Ophthalmology Portfolio
4 min read • 2 years ago -
Formulation ServicesLifecore Biomedical Partners with Nirsum Labs to Advance Addiction Treatment
4 min read • 2 years ago -
Manufacturing ServicesMerck’s $2 Billion Deal with Hansoh for Oral Obesity Drug
4 min read • 2 years ago -
Drug Delivery & PackagingBig Pharma Layoffs Surge in 2024 Amid Industry Challenges
4 min read • 2 years ago -
Manufacturing ServicesiBio’s $29M Deal with AstralBio for Muscle-Preserving Obesity Treatment
4 min read • 2 years ago -
-
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.







